Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Clark Golestani
AddedFeb 15, 2024
UpdatedJun 28, 2026
Clark Golestani

Clark Golestani

Board Member, Molecula

CrunchbaseLinkedInThe Org

Clark Golestani's Career

Molecula
Molecula

Austin, TX, US

Board Member· Board
Zapata Computing
Zapata Computing

Cambridge, MA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Clark Golestani's Career

Molecula
Molecula

Austin, TX, US

Board Member· Board
Zapata Computing
Zapata Computing
Series B$67.4M752017Cambridge, MA, US
Board Member· Board

Leadership at Zapata Computing

Gil BeydaGil BeydaBoard Member
Jeff HuberJeff HuberBoard Member
Mark CuptaMark CuptaBoard Member
Christopher SavoieChristopher SavoieCo-Founder
Rhonda Germany BallintynRhonda Germany BallintynBoard Member
Dana JonesDana JonesBoard Member

Similar to Zapata Computing

QuEra ComputingQuEra ComputingBoston, MA, USQuantum Computers, Softwareest. 2018QuEra ComputingBoston, MA, US · est. 2018

Boston-based QuEra Computing Inc. develops quantum computers and software for system simulations and optimization.

Series B · $17M62
Rigetti ComputingRigetti ComputingBerkeley, CA, USQuantum Computingest. 2013Rigetti ComputingBerkeley, CA, US · est. 2013

Rigetti: Pioneering cloud quantum computing for global challenges in health, energy, and AI.

Public · $298.4M144
QC WareQC WarePalo Alto, CA, USQuantum Softwareest. 2014QC WarePalo Alto, CA, US · est. 2014

Palo Alto-based Quantum Computing firm offering Enterprise Software and Services.

Series B · $41.4M55

Clark Golestani's Co-Investors

Matt WallachMatt WallachCo-invested · Curavit Clinical Research Series AVivek SoderaVivek SoderaCo-invested · SeedPat CondonPat CondonCo-invested · SeedEly KahnEly KahnCo-invested · SeedJohn StewartJohn StewartCo-invested · SeedRishi BhargavaRishi BhargavaCo-invested · Seed

Clark Golestani's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · KakaoSean JohSean JohBoard Member · Kakao

People Similar to Clark Golestani

Chris FashekChris FashekBoard Member · SpiracurVenkat SrinivasanVenkat SrinivasanBoard Member · English HelperCraig LipsetCraig LipsetBoard Member · MedVectorDan WatkinsDan WatkinsBoard Member · DatabasedJames FoghtJames FoghtBoard Member · OncolyzeDavid MahoneyDavid MahoneyBoard Member · Corcept Therapeutics